HOME CANCER GLOSSARY  CANCER PHOTOS  NEW CANCER BOOKS  LINKING  ADVERTISE

   
 

Free Financial Help for Cancer Patients
Gov't regulated program

Breast Cancer "Switch" Found

Cancer Pictures

Best Natl Cancer Ctrs

Cancer Centers
by State


Cancer Societies

Newest Treatments
by cancer type

MyCancerNews.com

Cancer Newsletters

Medical Journals

Cancer Calculator

Nat'l Cancer Inst.

MedLine Cancer

Chemotherapy

Other helpful links

Additional Help
for Cancer Patients

More Cancer Photos

Breast Cancer Current Topics in Breast Cancer

African American Disparities in Breast Cancer


Medically Reviewed On: March 31, 2006

While breast cancer is less common in minorities, African American women may have more reason to be concerned than whites after a diagnosis of breast cancer.

Two studies published in the Journal of Clinical Oncology highlight a racial gap in breast cancer mortality and, while it is still unclear what role it plays in mortality rates, one finds that minorities in general are less likely to receive the best breast cancer treatment.

In the first study, researchers from the University of Michigan compared the mortality rates of over 14,000 African American women and 76,000 white women with breast cancer. After eliminating socioeconomic factors, they found that African American women are 19 times more likely to die from breast cancer than white women who have the same stage of cancer. This evidence disputes the common belief that African American women have lower survival rates because they are diagnosed later than whites.

"Much of the racial disparity in breast cancer mortality has been attributed to later diagnosis." wrote Dr. Nina A. Bickell, associate professor of health policy and medicine at Mount Sinai. "Yet, even within stage categories, mortality rates are higher for minority women."

In the study, Dr. Lisa Newman suggests that biologic, genetic, cultural and societal factors may cause higher mortality rates in African American women with breast cancer.

To further elucidate one possible cause for the higher mortality rates, Bickell looked at the use of adjuvant breast cancer treatment—chemotherapy given after surgery to kill any remaining cancer cells—in minority women with early-stage breast cancer. Adjuvant chemotherapy greatly reduces the risk of cancer recurrence and is considered to be the standard of care for patients after breast cancer surgery. Comparing treatment in 677 women with breast cancer, Bickell found that 34 percent of blacks and 23 percent of Hispanics were not given chemotherapy after surgery as compared to only 16 percent of whites.

"Our finding highlights just how much progress could be made to eliminate cancer death and suffering by closing the gap on racial disparities in breast cancer treatment." said Bickell.

While her study was conducted in New York City, where there is an abundance of care centers, Bickel believes that part of the reason minority women receive less care is that they are less likely to have health insurance. Additionally, these women were also found to be less likely to speak with an oncologist concerning their care.

"Instituting a required oncology consultation may reduce racial disparities in care." said Bickel, who further explained that better communication between patient and doctor would also help improve care for minorities with breast cancer.

RELATED PROGRAMS
 

Alternative Therapies

Melanoma Skin Cancer

Complementary and Alternative Cancer
Care Guidelines

Cancer Treatment Research Library

Dangerous Doctors
...is yours safe?

Cancer Archives

 

 

MEMBERSHIPS:     

About us
Privacy policy
Conditions of use

 


Nat'l Cervical
Cancer Coalition

logo nbtf
National Brain
Tumor
Foundation


Nat'l Ovarian
Cancer Coalition


Breast Cancer
Research

MCN
My
Cancer News

 

Special
Thanks
 TECH SUPPORT

Codebrain
Codebelly


NOTICE:  No information on this CANCER research site is provided, intended or implied to substitute for trained, professional medical advice, CANCER diagnosis or CANCER treatmentAs a condition of use of this cancer website, all visitors agree to seek trained medical advice before using any cancer treatment or cancer information found on this website and agree discuss these with their physicians prior to use and to hold RobertsReview and all entities affiliated with, contributing to, and/or operating this cancer research website harmless in regard to all information provided herein and/or from any decisions that may flow from use of this information.  RobertsReview in no way recommends, endorses or verifies the accuracy or claims of any of the cancer information provided herein by "third parties" regardless of their affiliation.

©1997-2006 RobertsReview, Wickford, RI USA. No information contained on this website may be reproduced in any form in any media.  Single copies may be reprinted for non-commercial use.